RSC-1255
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RSC-1255, covering 2026-03-18 to 2026-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies [Phase 1]